Cite
HARVARD Citation
Ottoson, N. et al. (n.d.). P859 Association of immunopharmacodynamic responses of imprime PGG plus pembrolizumab with clinical benefit in metastatic triple negative breast cancer (TNBC) subjects failing front-line chemotherapy. Journal for immunotherapy of cancer. pp. A8-A9. [Online].